Objective: To compare the need of mechanical ventilation between LISA (less invasive surfactant administration) method and conventional INSURE method (INtubation SURfactant administration and Extubation) in spontaneously breathing preterm infants with respiratory distress syndrome (RDS). Study Design: An experimental study. Place and Duration of Study: Department of Neonatology, PIMS, Islamabad, from April to December 2017. Methodology: A total of 100 preterm infants <34 weeks gestation, on nasal CPAP requiring fraction of inspire oxygen (FiO 2 ) >0.4, with respiratory distress syndrome (RDS) were included in the study and divided randomly into two groups, 50 each. Results: There were 28 (56%) males in LISA and 31 (62%) in the INSURE group. Median birth weight was 1300 grams (IQR 600) in LISA, while 1400 grams (IQR 400) in INSURE infants. C-section rate was 52% (n=26) and 48% (n=24) in LISA and INSURE, respectively. Pre-natal steroids were given to 38 patients (76%) in LISA and 30 patients (60%) in INSURE group. LISA patients had significantly less need of mechanical ventilation with p-value <0.05 {30% (n=15) vs. 60% (n=30)}. The median duration of mechanical ventilation was 40 hours (IQR 75) need for sedation and tracheal intubation; and has shown promising results with reduced need for mechanical ventilation, improved oxygenation, decreased duration of ventilation. [5] [6] [7] Currently, the literature regarding LISA technique among preterm infants is limited. It may have a prominent role in future care of preterm infants with respiratory distress. In Pakistan, most of the neonatal units are using nCPAP, surfactant and mechanical ventilation in management of RDS. There is no published data from Pakistan on this technique.
INTRODUCTION
Respiratory distress syndrome (RDS) remains one of the major reasons of neonatal mortality and morbidity in preterm infants. 1 It is caused by surfactant deficiency leading to atelectasis and ventilation perfusion (V/Q) mismatch. It presents with tachypnea, cyanosis, retractions, and grunting (due to partial closure of glottis). Surfactant reduces the surface tension of alveoli, thereby preventing alveolar collapse during expiratory phase with improved lung compliance. The use of exogenous surfactant therapy and ventilation has improved the outcome of preterm neonates with RDS since 1990s. 1 Nasal continuous positive airway pressure (nCPAP) is increasingly used for RDS to reduce acute lung trauma. Surfactant therapy combined with nCPAP for alveolar recruitment has revolutionized the management of RDS. 1, 2 Surfactant is conventionally being given via endotracheal tube. Neonatal units are now adopting a gentle and non-invasive method for respiratory support in preterm infants in an attempt to avoid the complications of endotracheal intubation. Verder et al. introduced the INSURE technique, named after the three key stages in the procedure: INtubation, SURfactant administration followed by quick Extubation to reduce acute lung injury. 1, 2 This new technique aimed to avoid mechanical ventilation. Infants were provided nCPAP for respiratory support after the procedure. This approach reduces the alveolar injury compared to mechanical ventilation and the incidence of bronchopulmonary dysplasia (BPD). 3, 4 Though this method is considered safe, but still requires brief period of positive airway pressure ventilation after administration of surfactant.
INSURE method was further modified to avoid even this brief positive pressure ventilation. Kribs et al. used minimally invasive surfactant therapy (MIST), also called less invasive surfactant administration (LISA) with the aim to prevent intubation for surfactant delivery. 5 This technique ensures continuous uninterrupted nCPAP throughout the entire procedure; hence, temporary loss of functional lung capacity and atelectasis during the intubation can be prevented. Surfactant is administered into the trachea by direct laryngoscopy, via a thin tube (4-5 FG feeding tube) through the vocal cords, while the infant remains on nCPAP. After surfactant administration, the tube is immediately removed. LISA can avoid the need for sedation and tracheal intubation; and has shown promising results with reduced need for mechanical ventilation, improved oxygenation, decreased duration of ventilation. [5] [6] [7] Currently, the literature regarding LISA technique among preterm infants is limited. It may have a prominent role in future care of preterm infants with respiratory distress. In Pakistan, most of the neonatal units are using nCPAP, surfactant and mechanical ventilation in management of RDS. There is no published data from Pakistan on this technique.
The aim of this study was to compare results in infants receiving surfactant with LISA technique to those treated with INSURE technique.
METHODOLOGY
This experimental study was conducted in Neonatal Unit of Pakistan Institute of Medical Sciences (PIMS), Islamabad, from April till December 2017. Approval was taken from Institutional Ethical Review Board. A written informed consent was taken from parents for participation in the study.
Serial numbers from 1-100 were randomized divided into two groups using a web-based randomization tool (www.randomizer.org). Subjects were assigned the treatment group in order of their enrolment number. All the spontaneously breathing preterm neonates born in MCH (Mother and Child Health) Center, PIMS at <34 weeks of gestation, who developed RDS, were included in the study. Both groups were placed on nCPAP with FiO 2 adjusted to maintain O 2 saturations of 88-92%. They were given surfactant, if they needed FiO 2 of >0.4 during first 12 hours of life. All those premature neonates having major congenital malformations and those who required intubation for resuscitation at birth were excluded from study population.
RDS was diagnosed on the basis of prematurity, tachypnea with respiratory rate >60/minute, subcostal or intercostal chest recession, grunting, nasal flaring, and cyanosis. Radiological findings of RDS were bilateral diffuse reticular granular (ground glass) appearance, air bronchograms and poor lung expansion. They were placed initially on nCPAP to maintain SpO 2 . Sample size was calculated according to WHO sample size calculator. The proportion of population requiring intubation in the LISA group was assumed to be 43%, while the proportion of population requiring intubation in INSURE group was 73%. 8 Using sample size calculator, the final estimated sample for a study with 80% power and 95% confidence interval, was 43 patients for each group. Fifty patients were included in each group to cater for dropouts.
All the babies enrolled in study were initially placed on nCPAP (infant flow driver device, Care Fusion, Sandiego, CA). Respiratory support was provided with an initial pressure of 5 to 7 cm of water and FiO 2 of 0.3. They were randomized into two groups for the technique of surfactant administration, LISA or INSURE. In LISA group, surfactant was administered at a dose of 100 mg/Kg of Survanta with the help of size 6 Fr nasogastric tube. Upper respiratory tract was visualized with laryngoscope and the catheter was passed 1-2 cm past the vocal cords. Surfactant was delivered within 1-3 minutes in small aliquots, while the infant continued breathing with nCPAP, during and after the procedure. If catheterization was not possible in 20-30 seconds, the procedure was discontinued and attempted once again, when the baby was stable. The tracheal catheter was removed immediately after the procedure. Infant's heart rate and SpO 2 were monitored during the procedure via pulse oximetry. FiO 2 was adjusted to attain a target SpO 2 . Subsequent dose of surfactant was given, if infants met inclusion criteria again in first 12-24 hours. If infant's requirement of FiO 2 >0.4 or severe work of breathing, or persistent apneas were present then the patients were mechanically ventilated. This procedure was performed by senior neonatologists themselves who were experienced in carrying out intratracheal catheterization.
In the second group, i.e. the INSURE group, the infants were intubated and surfactant was administered successfully in 2-3 aliquots with endotracheal tube with same dose as in LISA group, while they received positive pressure ventilation via T-piece resuscitaire. After a brief period of positive pressure ventilation for 15-20 minutes, the endotracheal was removed and the infants were placed on nCPAP. The criteria for subsequent dose of surfactant and mechanical ventilation were the same as in LISA group. All the data variables were recorded for both groups on a specifically designed proforma.
Data was entered and analyzed through SPSS version 21. Mean ±SD (standard deviation values) were calculated for quantitative data, following normality. Median along with Interquartile range (IQR) was calculated the quantitative data which was not following normal distribution. Frequencies and percentages were presented for categorical data. Chi-square test along with Fischer exact test were applied for qualitative data, and independent sample t-test was used for quantitative data. The quantitative data was tested for normality by Kolmogorov-Smirnov test and the variables which were not following normality were compared with MannWhitney U-test. P-value <0.05 was deemed significant. spontaneously breathing babies, who fulfilled our inclusion criteria, were enrolled in study group, each comprising 50 newborns. The demographic data showed no significant difference in both groups. There were 28 (56%) male newborns in LISA group and 31 (62%) male newborns in INSURE group (p-value 0.542). The median birth weight of babies in LISA group was 1300 grams, IQR 600 grams; and in INSURE group, the median birth weight was 1400 grams, IQR 400 grams with no significant difference in both groups (p-value 0.204). Cesarean section frequency was 52% n=26 in LISA, while 48% n=24 in INSURE group. Demographics are shown in Table I .
The catheter was passed properly and surfactant was delivered successfully in all the patients in LISA group. Only one patient needed a second attempt of intratracheal catheterization. None of them required intubation for surfactant administration. Similarly, surfactant was given successfully to all patients in INSURE group via endotracheal tube. The results of the neonatal outcomes between the two groups are shown in Table II The duration of hospital stay showed a similar trend in both groups with median hospital stay of 7 days(IQR 5) in LISA group and 6 days (IQR 4) in INSURE group, with p-value of 0.304 as given in Table II .
DISCUSSION
RDS is a serious lung condition in preterm infants. Surfactant use has led to decreased respiratory morbidity and mortality due to RDS. 4, 9, 10 Nowadays, most preterm with RDS are treated initially with nCPAP, though certain number of neonates still need surfactant therapy to improve their respiratory outcomes. 10 In these infants, intubation is solely needed to administer surfactant into the lungs. INSURE is used as conventional method in most centers to provide surfactant therapy. LISA has been introduced as an alternative to this, but its influence on the overall neonatal outcome is yet to be evaluated.
LISA mainly depends on the spontaneous breathing effort of the preterm baby to distribute surfactant in lungs, instead of repeated positive pressure ventilation used during INSURE technique. This can avoid atelectasis associated even with brief intubation and ventilation. [11] [12] [13] Feasibility, safety, and efficacy of various LISA techniques have been compared in prospective RCTs and observational trials with similar short term results compared with the standard approach. 13, 14 In the present study, all the patients received surfactant successfully. A second attempt of catheterization was needed in one patient only.
Various studies have demonstrated a positive outcome with LISA with regard to FiO 2 reduction and ventilation. [14] [15] [16] It was observed significant reduction in FiO 2 after the surfactant delivery (median 30% IQR 30 vs. 25% IQR 10 in LISA and INSURE group, respectively). In contrast to the above findings, Ramos and colleagues showed nonsignificant difference between the LISA and standard groups, 73.3% vs. 86.6%. 8 In this study, a significant difference was found in the need for mechanical ventilation as well as duration of ventilation between the two groups. With the use of LISA technique, the outcome of the premature infants with RDS can be improved, reducing the cost of hospital stay and complications of mechanical ventilation by avoiding intubation.
CONCLUSION
Compared to INSURE, the LISA method has been found to be more effective in managing preterm babies with RDS along with nCPAP, and thereby preventing complications due to intubation and mechanical ventilation. This procedure can be performed even in level II NICU where the facility of nasal CPAP is available. In our healthcare system with limited resources, this method can be promising and effective step, which is feasible, cost-effective, and safe.
